Literature DB >> 25805235

The Platelet-to-Lymphocyte Ratio Versus Neutrophil-to-Lymphocyte Ratio: Which is Better as a Prognostic Factor in Gastric Cancer?

Eun Young Kim1, Jin Won Lee1, Han Mo Yoo1, Cho Hyun Park1, Kyo Young Song2.   

Abstract

BACKGROUND: As indicators of the systemic inflammatory response, the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) have been proposed to predict the clinical outcome in some cancers. The purpose of this study was to investigate the impact of NLR and PLR on the prognosis of gastric cancer.
METHODS: From 2000 to 2009, 1986 consecutive patients who underwent curative surgery for gastric cancer were enrolled. The optimal cutoff value of PLR and NLR was determined according to receiver operating characteristic analysis. We categorized the patients into the high or low PLR and NLR group based on the cutoff value, and the clinical features of these two groups were comparatively analyzed.
RESULTS: The high NLR and PLR groups were significantly associated with poor prognosis. The NLR was an independent prognostic factor for overall survival [hazard ratio (HR) = 1.403; p = 0.023]; however, the PLR was not (p = 0.788).
CONCLUSIONS: Although both the PLR and NLR can reflect the prognosis, the NLR is more predictive of overall survival than the PLR.

Entities:  

Mesh:

Year:  2015        PMID: 25805235     DOI: 10.1245/s10434-015-4518-z

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  70 in total

1.  Prognostic impact of the combination of neutrophil-to-lymphocyte ratio and Glasgow prognostic score in colorectal cancer: a retrospective cohort study.

Authors:  Susumu Inamoto; Kenji Kawada; Ryosuke Okamura; Koya Hida; Yoshiharu Sakai
Journal:  Int J Colorectal Dis       Date:  2019-06-08       Impact factor: 2.571

2.  Pretreatment platelet-to-lymphocyte ratio is associated with the response to first-line chemotherapy and survival in patients with metastatic gastric cancer.

Authors:  Jin Wang; Jinglei Qu; Zhi Li; Xiaofang Che; Jing Liu; Yuee Teng; Bo Jin; Mingfang Zhao; Yunpeng Liu; Xiujuan Qu
Journal:  J Clin Lab Anal       Date:  2017-02-26       Impact factor: 2.352

3.  Prognostic value of the combination of pre- and postoperative C-reactive protein in colorectal cancer patients.

Authors:  Manabu Yamamoto; Hiroaki Saito; Chihiro Uejima; Akimitsu Tanio; Seigo Takaya; Teruhisa Sakamoto; Soichiro Honjo; Yoshihiko Maeta; Keigo Ashida; Yoshiyuki Fujiwara
Journal:  Surg Today       Date:  2018-06-26       Impact factor: 2.549

4.  Prognostic Significance of Platelet-Based Inflammatory Indicators in Patients with Gastric Cancer.

Authors:  Hiroaki Saito; Yusuke Kono; Yuki Murakami; Yuji Shishido; Hirohiko Kuroda; Tomoyuki Matsunaga; Yoji Fukumoto; Tomohiro Osaki; Keigo Ashida; Yoshiyuki Fujiwara
Journal:  World J Surg       Date:  2018-08       Impact factor: 3.352

5.  Preoperative NLR for predicting survival rate after radical resection combined with adjuvant immunotherapy with CIK and postoperative chemotherapy in gastric cancer.

Authors:  Yingchun Li; Chenyu Wang; Mengdan Xu; Cuicui Kong; Aibing Qu; Meng Zhang; Zhichao Zheng; Guirong Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2017-01-20       Impact factor: 4.553

6.  Pre-treatment Peripheral Neutrophil-Lymphocyte Ratio as a Prognostic Marker in Gastric Cancer.

Authors:  Monika Magdy; Tarek Hussein; Ahmed Ezzat; Ahmed Gaballah
Journal:  J Gastrointest Cancer       Date:  2019-12

7.  Significance of Preoperative Systemic Inflammation Score in Short-Term and Long-Term Outcomes of Patients with Pathological T2-4 Gastric Cancer After Radical Gastrectomy.

Authors:  Bin Sato; Mitsuro Kanda; Chie Tanaka; Daisuke Kobayashi; Naoki Iwata; Norifumi Hattori; Masaya Suenaga; Masamichi Hayashi; Suguru Yamada; Kenta Murotani; Michitaka Fujiwara; Yasuhiro Kodera
Journal:  World J Surg       Date:  2018-10       Impact factor: 3.352

8.  Comparison of Prognostic Abilities Among Preoperative Laboratory Data Indices in Patients with Resectable Gastric and Esophagogastric Junction Adenocarcinoma.

Authors:  Masayuki Urabe; Hiroharu Yamashita; Toshiaki Watanabe; Yasuyuki Seto
Journal:  World J Surg       Date:  2018-01       Impact factor: 3.352

9.  Pretreatment neutrophil-to-lymphocyte ratio plus albumin-to-gamma-glutamyl transferase ratio predict the diagnosis of grade III glioma.

Authors:  Zhen-Qiang He; Hao Duan; Fu-Hua Lin; Ji Zhang; Yin-Sheng Chen; Guan-Hua Zhang; Cheng-Cheng Guo; Chao Ke; Xiang-Heng Zhang; Zheng-He Chen; Jian Wang; Zhong-Ping Chen; Xiao-Bing Jiang; Yong-Gao Mou
Journal:  Ann Transl Med       Date:  2019-11

10.  A nomogram combining plasma fibrinogen and systemic immune‑inflammation index predicts survival in patients with resectable gastric cancer.

Authors:  Pan-Xing Wang; Hai-Jiang Wang; Jia-Huang Liu; Guang-Lin Qiu; Jing Lu; Lin Fan; Xin-Hua Liao; Xiang-Ming Che
Journal:  Sci Rep       Date:  2021-05-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.